Equillium Inc. share price logo

Equillium Inc.

NASDAQ: EQ

$2.62

-0.14

(-5.07%)

as on

Equillium Inc. Stock Performance

as on July 16, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.52
    $2.79
    downward going graph

    3.82%

    Downside

    6.49%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.36
    $3.54
    downward going graph

    86.25%

    Downside

    35.11%

    Upside

    downward going graph

Equillium Inc. share price movements today

Previous Close
$2.76
Open
$2.77
Volume
807.6K
Day's Low - High
$2.52 - $2.79
52 Week Low - High
$0.36 - $3.54

Equillium Inc. Historical Returns

1 Month Return
-4.73 %
3 Month Return
+ 32.32 %
1 Year Return
+ 531.48 %
3 Year Return
+ 202.89 %
5 Year Return
-53.21 %

Equillium Inc. Stock Fundamentals & Key Indicators

Check Equillium Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$165.7M

EPS (TTM)

-0.2414

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-20.3M

Revenue (TTM)

4.4M

Profit Margin

0.00%

Return On Equity TTM

-54.39%

Equillium Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Equillium Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Equillium Inc. image
Equillium Inc.
BUY$165.7M-53.21%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.1B518.72%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.9B135.85%28.4935.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$68.8B13.92%16.1829.65%0.54%

Stock Returns calculator for Equillium Inc. Stock including INR - Dollar returns

The Equillium Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Equillium Inc. investment value today

Current value as on today

₹7,16,777

Returns

₹6,16,777

(+616.78%)

Returns from Equillium Inc. Stock

₹5,39,024 (+539.02%)

Dollar Impact

₹77,753 (+77.75%)

Analyst Recommendation on Equillium Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Equillium Inc.. Average target price of $8.56

Equillium Inc. Share Price Target

Get share price movements and forecasts by analysts on Equillium Inc..

What analysts predicted

69.39%UPSIDE

Target Price

$8.56

Current Price

$2.62

Analyzed by

12 Analysts

Target

$8.56

Equillium Inc. target price $8.56, a slight upside of 69.39% compared to current price of $2.62. According to 12 analysts rating.

Indian Investors' Interest in Equillium Inc. Stock

Search interest for Equillium Inc. Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-3% versus previous 30 day period

Equillium Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
9
10
13
12
4
-
-
-
-
-
Gross Profit
9
10
13
12
4
0
0
0
0
0
Operating Income
-3
-2
0
0
-4
-8
-6
-4
-3
-5
EBITDA
-2
-2
0
0
-5
-8
-5
-4
-3
-5
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
0
0
-5
-8
-5
-4
-3
-5
Income Tax Expense
0
0
-
-
0
-
-
-
-
-
Net Income
-2
-2
0
0
-5
-8
-5
-4
-3
-5
Net Profit Margin
-25.43%
-25.58%
3.38%
-0.06%
-131.92%
0.00%
0.00%
0.00%
0.00%
0.00%

Equillium Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
15
36
41
0
Gross Profit
0
0
0
0
0
15
36
41
0
Operating Income
-1
-8
-26
-29
-37
-62
-14
-8
-23
EBITDA
-1
-8
-26
-29
-37
-61
-12
-7
-22
Interest Expense
0
2
0
1
1
1
0
-
-
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-2
-13
-25
-29
-39
-62
-12
-7
-22
Income Tax Expense
0
0
0
0
0
45
0
0
-
Net Income
-2
-13
-25
-29
-38
-62
-13
-8
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-396.14%
-36.96%
-19.63%
-17229.23%

Equillium Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
0
0
-5
-8
-5
-4
-3
-5
Operating Cash Flow
-8
0
-7
-3
-8
-3
-8
-3
-4
Investing Cash Flow
-2
-1
12
5
4
-
-
0
0
Financing Cash Flow
-
0
-
0
0
0
30
0
35
Change in Cash
-11
0
4
2
-3
-3
21
-2
31

Equillium Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-25
-29
-39
-62
-13
-8
-22
Operating Cash Flow
-7
-22
-24
-32
-8
-21
-19
-22
Investing Cash Flow
-37
-2
-18
27
18
-4
13
4
Financing Cash Flow
66
9
53
31
-1
-9
0
30
Change in Cash
21
-15
10
26
8
-35
-5
12

Global Institutional Holdings in Equillium Inc.

Funds
Holdings
UBS Group AG
0.14%
Geode Capital Management, LLC
0.6%
Ikarian Capital, LLC
0.48%
HHG PLC
10.27%
Apollon Wealth Management, LLC
0.02%
See all

Insights on Equillium Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EQ has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 591.8% return, outperforming this stock by 388.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EQ stock has moved down by -11.5%

About Equillium Inc.

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
OrganisationEquillium Inc.
Headquarters2223 Avenida De La Playa, La Jolla, CA, United States, 92037
IndustryBiotechnology
CEOMr. Bruce D. Steel
E-voting on sharesClick here to vote

Key Management of Equillium Inc.

Name

Title

Mr. Bruce D. Steel

Co-Founder, CEO & Director

Dr. Stephen Connelly Ph.D.

Chief Scientific Officer & President

Ms. Christine Zedelmayer M.B.A., P.M.P.

Senior VP & COO

Ms. Penny Tom CPA

Senior VP of Finance & Principal Accounting Officer

Mr. Michael Moore

Vice President of Investor Relations & Corporate Communications

Ms. Snehal Naik Ph.D.

Chief Development Officer

Dr. Lisette Acevedo

Vice President of Clinical Development

FAQs

What is Equillium Inc. share price today?

Equillium Inc. share price today is $2.62 as on at the close of the market. Equillium Inc. share today touched a day high of $2.79 and a low of $2.52.

What is the 52 week high and 52 week low for Equillium Inc. share?

Equillium Inc. share touched a 52 week high of $3.54 on and a 52 week low of $0.36 on . Equillium Inc. stock price today i.e. is closed at $2.62,which is 25.99% down from its 52 week high and 627.17% up from its 52 week low.

What is Equillium Inc.'s market capitalisation today?

Equillium Inc. market capitalisation is $0.00T as on .

How to invest in Equillium Inc. Stock (EQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Equillium Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Equillium Inc. Shares that will get you 0.5725 shares as per Equillium Inc. share price of $2.62 per share as on July 16, 2026 at 8:46 am IST.

What is the minimum amount required to buy Equillium Inc. Stock (EQ) from India?

Indian investors can start investing in Equillium Inc. (EQ) shares with as little as ₹96.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Equillium Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Equillium Inc. share’s latest price of $2.62 as on July 16, 2026 at 8:46 am IST, you will get 3.8168 shares of Equillium Inc.. Learn more about fractional shares .

What are the returns that Equillium Inc. has given to Indian investors in the last 5 years?

Equillium Inc. stock has given -53.21% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?